Liposomal cytarabine (DepoCyte™ injection) is cost-effective compared with standard cytarabine for the intrathecal treatment of patients with lymphomatous meningitis

被引:3
|
作者
Moeremans, K
Annemans, L
Morris, J
机构
[1] Hlth Econ & Dis Management, HEDM, Brussels, Belgium
[2] Nap Pharmaceut, Hlth Econ & Outcomes Res, Cambridge, England
关键词
D O I
10.1182/blood.V104.11.267.267
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
267
引用
收藏
页码:80A / 80A
页数:1
相关论文
共 50 条
  • [1] Use of intrathecal liposomal Cytarabine (DepoCyte) as treatment of lymphomatous meningitis.
    Cascavilla, Nicola
    Bodenizza, Carlo
    Carella, Angelo Michele
    Dell'Olio, Matteo
    Falcone, Antonietta
    Greco, Michele Mario
    La Sala, Antonio
    Mantuano, Saverio
    Melillo, Lorella
    Merla, Emanuela
    Nobile, Michele
    Sanpaolo, Grazia
    Scalzulli, Potito
    [J]. BLOOD, 2006, 108 (11) : 251B - 251B
  • [2] Intrathecal liposomal cytarabine as therapy of lymphomatous meningitis
    Cascavilla, N.
    Bodenizza, C.
    Carella, A. M.
    Dell'Olio, M.
    Falcone, A.
    Greco, M. M.
    La Sala, A.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Nobile, M.
    Sanpaolo, G.
    Scalzulli, P. R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 62 - 62
  • [3] Intrathecal liposomal cytarabine as therapy of lymphomatous meningitis
    Cascavilla, N.
    Bodenizza, C.
    Carella, A. M.
    Dell'Olio, M.
    Falcone, A. P.
    Greco, M. M.
    La Sala, A.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Nobile, M.
    Sanpaolo, G.
    Scalzulli, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 417 - 417
  • [4] Liposomal cytarabine (DepoCyte®) for the treatment of neoplastic meningitis
    Domínguez A.R.
    Hidalgo D.O.
    Garrido R.V.
    Sánchez E.T.
    [J]. Clinical and Translational Oncology, 2005, 7 (6) : 232 - 238
  • [5] TOLERABILITY AND TOXICITY OF TREATMENT WITH INTRATHECAL LIPOSOMAL CYTARABINE (DEPOCYTE) IN CHILDREN
    Stancokova, Terezia
    Husakova, Kristina
    Deak, Ladislav
    [J]. NEURO-ONCOLOGY, 2012, 14 : 17 - 17
  • [6] Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine
    Kripp, Melanie
    Hofheinz, Ralf-Dieter
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2008, 3 (04) : 397 - 401
  • [7] SURVIVAL AT 3, 6, 10, AND 12 MONTHS IN 22 PATIENTS WITH NEOPLASTIC MENINGITIS TREATED WITH INTRATHECAL LIPOSOMAL CYTARABINE (DEPOCYTE)
    Le Rhun, E.
    Baranzelli, M.
    Perret, M. Faivre
    Dubois, F.
    Bonneterre, J.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1115 - 1115
  • [8] Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis
    Glantz, MJ
    LaFollette, S
    Jaeckle, KA
    Shapiro, W
    Swinnen, L
    Rozental, JR
    Phuphanich, S
    Rogers, LR
    Gutheil, JC
    Batchelor, T
    Lyter, D
    Chamberlain, M
    Maria, BL
    Schiffer, C
    Bashir, R
    Thomas, D
    Cowens, W
    Howell, SB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3110 - 3116
  • [9] PHASE II STUDY OF INTRATHECAL LONG ACTING LIPOSOMAL CYTARABINE (DEPOCYTE®) IN THE PROPHYLAXIS OF LYMPHOMATOUS MENINGITIS IN HIV-RELATED NON-HODGKIN'S LYMPHOMA
    Spina, M.
    Martellotta, F.
    Berretta, M.
    Zanet, E.
    Lleshi, A.
    Canzonieri, V.
    Bulian, P.
    Bibas, M.
    Antinori, A.
    Uziel, L.
    Manna, A.
    Carbone, A.
    Tirelli, U.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 237 - 237
  • [10] PHASE II STUDY OF INTRATHECAL LONG ACTING LIPOSOMAL CYTARABINE (DEPOCYTE®) IN THE PROPHYLAXIS OF LYMPHOMATOUS MENINGITIS IN HIV-RELATED NON-HODGKIN'S LYMPHOMA
    Spina, Michele
    Chimienti, Emanuela
    Martellotta, Ferdinando
    Berretta, Massimiliano
    Zanet, Ernesto
    Nigri, Paola K.
    Canzonieri, Vincenzo
    Bulian, Pietro
    Tirelli, Umberto
    [J]. ANNALS OF ONCOLOGY, 2009, 20